In mouse models, the expression of p210 has been associated with slowly progressive CML-like disease while p190 is associated with short latency and acute B-cell leukemia, suggesting the contribution of Bcr-Abl isoforms to specific fates [18, 19]. This evidence concerns the gene CNTNAP1 and chronic myelogenous leukemia, BCR-ABL1 positive.